Whole-body MRI for the Detection of Metastasis
Overview
Develop and optimize protocols for whole body MRI for detection of metastases. Evaluate diagnostic accuracy through application of optimized protocols for screening of cancer patients.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: March 2018
Arms, Groups and Cohorts
- Advanced breast cancer
- Women with advanced breast cancer
Clinical Trial Outcome Measures
Primary Measures
- Number of metastasis in skeleton
- Time Frame: Baseline and after 6 months
- Number of skeleton metastasis will be assessed at the regular clinical follow-up of breast cancer patients with metastatic disease
Participating in This Clinical Trial
Inclusion Criteria
- Cancer patient Exclusion Criteria:
- Poor general condition – Pacemaker or other MRI contraindications
Gender Eligibility: Female
Minimum Age: 18 Years
Maximum Age: 95 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Norwegian University of Science and Technology
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Beathe Sitter, PhD, Principal Investigator, Norwegian University of Science and Technology
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.